Dr. Alan Fogelman, MD

• Cardiology

• Internal Medicine

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• University Of California-los Angeles

  Fellowship Hospital, 1973

• Ucla Hospital

  Residency Hospital, 1968

• Ucla Hospital

  Internship Hospital, 1967

• University Of California, Los Angeles David Geffen School Of Medicine

  Medical School, 1966

• ApoA-I mimetics reduce systemic and gut inflammation in chronic treated HIV, 2022-01-07

• ApoE-/-Mice Lacking Hemopexin Develop Increased AtherosclerosisviaMechanisms That Include Oxidative Stress and Altered Macrophage Function, 2016-04-14

• NOTCH1 is a mechanosensor in adult arteries, 2017-11-20

• In vitro stimulation of HDL anti-inflammatory activity and inhibition of LDL pro-inflammatory activity in the plasma of patients with end-stage renal disease by an apoA-1 mimetic peptide, 2009-05-27

• HIV-1 infected patients with suppressed plasma viremia on treatment have pro-inflammatory HDL, 2011-02-23

• Role of enterocyteEnpp2and autotaxin in regulating lipopolysaccharide levels, systemic inflammation, and atherosclerosis, 2023-04-12

• Genetic Regulation of Atherosclerosis-Relevant Phenotypes in Human Vascular Smooth Muscle Cells, 2020-10-12

• Treating the Intestine with Oral ApoA-I Mimetic Tg6F Reduces Tumor Burden in Mouse Models of Metastatic Lung Cancer, 2018-06-13

• Treatment with apolipoprotein A-1 mimetic peptide reduces lupus-like manifestations in a murine lupus model of accelerated atherosclerosis, 2010-05-18

• ApoA-I Mimetic Peptide 4F Rescues Pulmonary Hypertension by Inducing MicroRNA-193-3p, 2014-06-24

• PON2 Deficiency Leads to Increased Susceptibility to Diet-Induced Obesity, 2019-01-11

• Ambient Ultrafine Particle Ingestion Alters Gut Microbiota in Association with Increased Atherogenic Lipid Metabolites, 2017-02-17

• HDL mimetics inhibit tumor development in both induced and spontaneous mouse models of colon cancer, 2012-03-13

• D-4F, an apoA-I mimetic peptide, inhibits proliferation and tumorigenicity of epithelial ovarian cancer cells by upregulating the antioxidant enzyme MnSOD, 2011-05-26

• Paraoxonase 2 overexpression inhibits tumor development in a mouse model of ovarian cancer, 2018-03-12

• Phospholipid remodeling and cholesterol availability regulate intestinal stemness and tumorigenesis, 2018-02-01

• L-5F, an apolipoprotein A-I mimetic, inhibits tumor angiogenesis by suppressing VEGF/basic FGF signaling pathways, 2011-02-01

• Structure and Function of HDL Mimetics, 2009-07-16

• ApoA-I mimetic administration, but not increased apoA-I-containing HDL, inhibits tumour growth in a mouse model of inherited breast cancer, 2016-11-03

• Oxpholipin 11D: An Anti-Inflammatory Peptide That Binds Cholesterol and Oxidized Phospholipids, 2010-04-14

• Forty Year Anniversary ofArteriosclerosis, Thrombosis, and Vascular Biology, 2021-08-25

• Mitogen-Activated Protein Kinase Phosphatase-1 Deficiency Decreases Atherosclerosis in Apolipoprotein E Null Mice by Reducing Monocyte Chemoattractant Protein-1 Levels, 2010-06-09

• Effects of lipid-probe interactions in biochemical fluorometric methods that assess HDL redox activity, 2012-07-06